Anhui University of Traditional Chinese Medicine, College of Traditional Chinese Medicine, Hefei, China.
The Second Clinical Medical School, Anhui University of Traditional Chinese Medicine, Hefei, China.
J Ethnopharmacol. 2024 Dec 5;335:118641. doi: 10.1016/j.jep.2024.118641. Epub 2024 Jul 29.
As one of the most serious microvascular complications of diabetes mellitus (DM), diabetic retinopathy (DR) can cause visual impairment and even blindness. With the rapid increase in the prevalence of DM, the incidence of DR is also rising year by year. Preventing and effectively treating DR has become a major focus in the medical field. Traditional Chinese medicine (TCM) has a wealth of experience in treating DR and has achieved significant results with various herbs and TCM prescriptions. Traditional Chinese Medicine (TCM) provides a comprehensive therapeutic strategy for diabetic retinopathy (DR), encompassing anti-inflammatory and antioxidant actions, anti-neovascularization, neuroprotection, regulation of glucose metabolism, and inhibition of apoptosis. This review provides an overview of the current status of TCM treatment for DR in recent years, including experimental studies and clinical researches, to explore the clinical efficacy and the underlying modern mechanisms of herbs and TCM prescriptions. Besides, we also discussed the challenges TCM faces in treating DR, such as drug-drug interactions among TCM components and the lack of high-quality evidence-based medicine practice, which pose significant obstacles to TCM's application in DR.
糖尿病视网膜病变(DR)是糖尿病(DM)最严重的微血管并发症之一,可导致视力损害甚至失明。随着 DM 患病率的迅速增加,DR 的发病率也逐年上升。预防和有效治疗 DR 已成为医学领域的重点。中药(TCM)在治疗 DR 方面有丰富的经验,各种草药和 TCM 方剂已取得显著成效。中药(TCM)为糖尿病视网膜病变(DR)提供了全面的治疗策略,包括抗炎和抗氧化作用、抗新生血管形成、神经保护、调节葡萄糖代谢和抑制细胞凋亡。本文综述了近年来中药治疗 DR 的实验研究和临床研究现状,探讨了草药和 TCM 方剂的临床疗效和潜在的现代机制。此外,我们还讨论了中药治疗 DR 面临的挑战,如 TCM 成分之间的药物相互作用以及缺乏高质量的循证医学实践,这对 TCM 在 DR 中的应用构成了重大障碍。